On this week’s Tech Nation, Frontline Stories from Ukraine’s International Legion with Military Historian Dr. Shannon Monaghan, for Type I diabetics, the New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without immunosuppressant drugs, and Daniel Kraft reports in on the BioTech Nation session from NextMed Health 2025.